Drug-based pain management in people with dementia after hip or pelvic fractures: a systematic review protocol.

Syst Rev

Institute for Health Services Research and Health Economics, Faculty of Medicine, Economics, Heinrich-Heine-University, Moorenstraße 5, 40225, Düsseldorf, Germany.

Published: July 2016

Background: Studies show that people with dementia do not receive the same amount of analgesia after a hip or pelvic fracture compared to those without cognitive impairment. However, there is no systematic review that shows to what extent and how drug-based pain management is performed for people with dementia following a hip or pelvic fracture. The aim of this systematic review is to identify studies addressing drug-based pain management for people with dementia who have had a hip or pelvic fracture for which they had either an operation or conservative treatment. We will analyse to what extent and how the drug-based pain treatment for people with dementia is performed across all settings and how it is assessed in the studies.

Methods: The development of this systematic review protocol was guided by the PRISMA-P requirements, which will be taken into consideration during the review procedure. MEDLINE, EMBASE, CINAHL, Web of Knowledge and ScienceDirect will be searched, using keywords such as "analgesia", "dementia", "cognitive impairment", "pain treatment", "hip fracture" or "pelvic fracture". Publications published up to January 2016 will be included. The data extraction and a content analysis will be carried out systematically, followed by a critical appraisal.

Discussion: This review will provide a valuable overview on the current evidence on drug-based pain management for PwD in all settings who were conservatively treated after a hip or pelvic fracture. The review may expose a need to enhance pain management for PwD. It may also provide motivation for healthcare providers and policymakers to give this topic their attention and to facilitate further research by considering aspects of care transitions in all settings.

Systematic Review Registration: PROSPERO CRD42016037309.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944510PMC
http://dx.doi.org/10.1186/s13643-016-0296-3DOI Listing

Publication Analysis

Top Keywords

drug-based pain
20
pain management
20
people dementia
20
hip pelvic
20
systematic review
16
pelvic fracture
16
dementia hip
12
management people
8
review
8
review protocol
8

Similar Publications

Background: Physiotherapy has emerged as an important health strategy to deliver lifestyle, exercise and physical activity for people with knee osteoarthritis. However, little is known about the extent to which physiotherapists adhere to clinical practice guidelines. This study aimed to explore the perspectives and care patterns of physiotherapists in Sydney, Australia on their delivery of knee osteoarthritis care and how this aligns with the 2019 Osteoarthritis Research Society International (OARSI) guidelines.

View Article and Find Full Text PDF

Preventing social defeat stress-induced behavioural and neurochemical alterations by repeated treatment with a mix of , and standardized extracts.

Front Pharmacol

August 2024

Section of Pharmacology and Toxicology, Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy.

Prolonged exposure to stress is a risk factor for the onset of several disorders. Modern life is burdened by a pervasive prevalence of stress, which represents a major societal challenge requiring new therapeutic strategies. In this context, botanical drug-based therapies can have a paramount importance.

View Article and Find Full Text PDF

Background: Gout remains a leading cause of inflammatory arthritis worldwide, and the main risk factor for gout is persistent hyperuricemia. The clinical management of gout is mostly drug-based, and other treatment options are often ignored. This research proposal will explore whether exergames combined with ice therapy can help patients with gout to lose weight, relieve pain, improve the range of movement, improve quality of life, decrease uric acid level, decrease kinesiophobia and improve mental health of patients with gout.

View Article and Find Full Text PDF

Psychometric properties and domains covered by patient-reported outcome measures used in trials assessing interventions for chronic pain.

J Clin Epidemiol

June 2024

Centre d'Epidémiologie Clinique, Hôpital Hôtel-Dieu, AP-HP, Paris, France; Université Paris Cité, CRESS, INSERM, INRAE, Paris, France. Electronic address:

Objectives: To identify the patient-reported outcome measures (PROMs) used in clinical trials assessing interventions for chronic pain, describe their psychometric properties, and the clinical domains they cover.

Study Design And Setting: We identified phase 3 or 4 interventional trials: on adult participants (aged >18 years), registered in clinicaltrials.gov between January 1, 2021 and December 31, 2022, and which provided "chronic pain" as a keyword condition.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to investigate the prevalence of wound-related pain (WRP) in patients with chronic wounds and the effectiveness of pain relief methods used.
  • Conducted in Jiangsu province, China, the cross-sectional study included 451 patients, primarily male (56.1%), with an average age of 54.85 years.
  • Findings revealed that 62.5% of patients experienced baseline pain, with a mean pain score of 3.76, while 93.8% felt procedural pain, peaking at a mean score of 6.45 during treatment, and the use of pain relief medications was notably low.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!